ExactAntigen

ATF2 Phosphospecific Antibody | Novus Biologicals antibody product information
request information:
Catalog Code:NB120-4734
Product Name:ATF2 Phosphospecific Antibody
Product Description:Rabbit Polyclonal anti-ATF2 [Thr69/Thr71]
Clonality:Polyclonal
ListPrice:325
Immunogen:Synthetic peptide (Human) derived from a region of human ATF2 that contains threonines 69 and 71. The sequence is conserved in mouse, rat, chicken and frog.
Cross Reactivity:Cross-reacts with Human.Expected to cross-react with Chicken (100% identity with immunogen), Mouse (100% identity with immunogen), Rat (100% identity with immunogen), Xenopus laevis (100% identity with immunogen) due to sequence homology.Not yet tested in other species.
Packaging:0.05 ml Immunogen affinity purified Rabbit IgG.
Uses:WB: Use at a concentration of 0.35 - 1.0 ug/ml. Predicted molecular weight: 60 kDa. Not tested in other applications.Optimal dilutions/concentrations should be determined by the end user.
Localization:Nuclear
Background:ATF2 (Activating Transcription Factor 2, CREBP, HB16, CREB2, TREB7) is a member of the ATF/CREB family of basic region leucine zipper DNA binding proteins that regulates transcription by binding to a consensus cAMP response element (CRE) in the promoter of various viral and cellular genes. Many of these genes are important in cell growth and differentiation, and in stress and immune responses. ATF2 is a nuclear protein that binds DNA as a dimer and can form dimers with members of the ATF/CREB and Jun/Fos families. It is a stronger activator as a heterodimer with cJun than as a homodimer. Several isoforms of ATF2 arise by differential splicing. The stable native full length ATF2 is transcriptionally inactive as a result of an inhibitory direct intramolecular interaction of its carboxy terminal DNA binding domain with the amino terminal transactivation domain. Following dimerization ATF2 becomes a short lived protein that undergoes ubiquitination and proteolysis, seemingly in a protein phosphatase-dependent mechanism. Stimulation of the transcriptional activity of ATF2 occurs following cellular stress induced by several genotoxic agents, inflammatory cytokines, and UV irradiation. This activation requires phosphorylation of two threonine residues in ATF2 by both JNK/SAP kinase and p38 MAP kinase. ATF2 is abundantly expressed in brain.
Storage:Store at −20oC. We recommend a brief centrifugation before opening to settle vial contents. Then, apportion into working aliquots and store at −20oC. For shipment or short-term storage (up to one week), 2-8oC is sufficient.
Purity:Immunogen affinity purified
Isotype:IgG
Host Name:Rabbit
Buffer:phosphate buffered saline (without Mg2+ and Ca2+), pH 7.3 (+/- 0.1), 50% glycerol with 1.0 mg/mL BSA
Application Summary:Western Blot
Species Summary:Hu,
Alternate Names:anti-Activating Transcription Factor 2 antibody, anti-cAMP Response Element Binding Protein 2 antibody, anti-CRE BP1 antibody, anti-CREB 2 antibody, anti-CREB2 antibody, anti-CREBP1 antibody, anti-HB 16 antibody, anti-HB16 antibody, anti-MGC111558 antibody, anti-mXBP antibody, anti-TREB 7 antibody, anti-TREB7 antibody
Package Size:0.05 ml
Preservative:0.05% sodium azide
Phosphorylated:Thr69/Thr71
General References:General / background references:Bhoumik A et al. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110:643-50 (2002). Bhoumik A et al. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110:643-50 (2002). Waas WF et al. The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways. J Biol Chem 276:5676-84 (2001). Miethe J et al. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2. Oncogene 20:8116-24 (2001).
order or
more information
:
company product webpage
Also see:
all human ATF2 antibodies


2008©ExactAntigen home | browse | about